On April 3, 2018, BIOCND Inc. (XKON:A217950) closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
26,450 KRW | -3.64% |
|
-6.70% | +31.59% |
1st Jan change | Capi. | |
---|---|---|
+31.59% | 77.59M | |
+16.61% | 122B | |
+17.75% | 112B | |
+17.23% | 25.91B | |
-24.11% | 19.33B | |
-18.56% | 16.17B | |
-18.47% | 15.6B | |
-47.75% | 14.65B | |
+57.35% | 14.34B | |
+5.62% | 14B |
- Stock Market
- Equities
- A217950 Stock
- News PHARMARESEARCH BIO Co., Ltd.
- BIOCND Inc. announced that it has received KRW 10 billion in funding from Pharma Research Products Co., Ltd